Alvotech Notches Up Another Stelara Biosimilar Approval – In Canada
Follows Japanese Approval As Well As EMA Nod For AVT04 Version Of Ustekinumab
Alvotech and local partner Jamp Pharma have received the first Canadian approval for an ustekinumab biosimilar rival to Stelara in the form of Jamteki, with Health Canada’s marketing authorization following earlier nods for Alvotech’s AVT04 candidate in other geographies.
